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ABSTRACT 
 
CHARACTERIZING FERROPTOSIS PATHWAYS IN IN VITRO MOTOR NEURON 
MODELS 
 
Alejandra Martinez 
 
 
 
 Ferroptosis is a non-apoptotic regulated form of cell death driven by the toxic 
accumulation of lipid peroxides and the presence of iron. The mechanism by which ferroptosis 
operates requires further investigation; here I will discuss the findings regarding the role of 
ferroptosis in different cellular models as well as the genes that may be involved with either 
promoting or hindering the ferroptotic pathway. NSC-34 is a hybrid cell line of neuroblastoma 
and primary spinal cord cells that can be differentiated into a motor neuron-like state allowing the 
characterization of ferroptosis in two distinct cellular conditions. Additionally, iNIL cells are a 
mouse embryonic stem cell line that can be efficiently differentiated into motor neurons and 
provides a viable cellular model to study ferroptosis in neuronal context. Contrarily, HT-1080 is 
the mother cell line in which ferroptosis was discovered, providing the best model to look at 
which genes are essential to drive ferroptosis. PPIP5K2 is a gene involved in phosphate 
homeostasis that, upon knockdown via siRNA transfection, showed rescue of cell death after 
ferroptosis induction. ACSL4 is another gene of interest since it is involved in lipid metabolism 
and lethal accumulation of lipid ROS is a hallmark of ferroptosis. Thus, generating stable cell 
lines with knockouts of such genes via lentiviral CRISPR transduction in both HT-1080 and 
mouse embryonic stem cells are essential to establish further connections.
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CHAPTER 1: INTRODUCTION 
Cell death modalities are increasingly investigated for their potential roles in 
various disease contexts, from cancer to neurodegeneration. Apoptosis is among the more 
well-established pathways. However, other cell death modalities such as ferroptosis and 
necroptosis are regulated non-apoptotic forms of cell death that require further 
characterization. While both are imperative in understanding their impact on cellular 
function and the possible roles they play in a pathological context, ferroptosis was the 
main focus of this study. This particular cell death pathway has yet to be fully 
characterized, lacking information on specific key regulators that facilitate it as well as its 
function and importance in varying cell models.  
Ferroptosis differs from other modes of cell death because it lacks the swelling of 
the cytoplasm and rupture of the cell membrane typical to necrosis1. It does not embody 
the morphological characteristics of apoptosis that include cell shrinkage, chromatin 
condensation, formation of apoptotic bodies and disintegration of the cytoskeleton1. 
While the formation of classical closed bilayer membrane structures such as autophagic 
vacuoles are the epitome of autophagy, this too is a feature uncommon in ferroptosis1. 
Ferroptosis manifests morphologically with an increased membrane density and 
shrinkage of the mitochondria1. Its most notable hallmarks are the production of cytosolic 
and lipid reactive oxygen species (ROS) as a result of metabolic dysfunction but 
independent of the mitochondria1. This accumulation of ROS to lethal amounts is iron 
dependent. The role of iron in catalyzing ferroptosis remains elusive yet crucial in driving 
cellular death either via Fenton chemistry or through enzymatic processes. 
 
2 
Glutathione peroxidase 4 (GPX4) is an enzyme containing eight nucleophilic 
amino acids, including seven cysteines and one selenocysteine enabling it to react with 
electrophiles in the cell2,3. Under normal physiological conditions, GPX4 is a key 
antioxidant in regulating oxidative stress by reducing toxic lipid peroxides to non-toxic 
lipid alcohols in the presence of its cofactor glutathione (GSH)2. GSH is a tripeptide 
composed of the three amino acids cysteine, glutamic acid, and glycine. Its antioxidant 
properties play a major role in maintaining cellular health since it serves as a scavenger 
of free radicals. If otherwise left unchecked, these free radicals have the potential to 
dismantle the cell. On the other hand, GSH also serves as a co-enzyme for GPX4, 
entering an oxidized state as GPX4 catalyzes the reduction of ROS. GSH can then be 
recycled by glutathione reductase and the duo can continue to minimize oxidative stress. 
During ferroptosis there are two major events that must occur to carry out the 
process; the first is an inhibition of the reduction of lipid peroxides. This inhibition 
transpires when GPX4 and GSH function is compromised. The second event is the 
formation of lipid peroxides which materializes via three distinct routes all of which are 
iron dependent: lipid ROS produced through the Fenton reaction by iron in a non-
enzymatic manner,  lipid peroxides produced by lipid autoxidation in an iron-catalyzed 
manner and lipid peroxides generated by oxygenation and esterification of 
polyunsaturated fatty acids (PUFAs)2,3. Whether any of these routes to generate lipid 
ROS is predominant in the ferroptotic pathway is still under investigation. In any case, 
the two major events promote an increase in lipid ROS to lethal amounts and highlight 
the importance of GPX4 and GSH; two main targets for many small molecules to induce 
ferroptosis. 
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Erastin and RSL3 are the two canonical drug inducers of ferroptosis via inhibition 
of system Xc and GPX4, respectively. These small molecules were the first ferroptosis-
inducing compounds discovered using high-throughput screening of small molecule 
libraries4,5. They were found to promote a type of cell death in conditions where both 
apoptosis and necroptosis hallmarks were repressed6. In the case of apoptosis this 
included caspases, BAX, and BAK; while for necroptosis both RIPK1 and RIPK3 were 
targeted6. Since these results deviated from the norm, it inspired further research and both 
erastin and RSL3 are now exceptionally well understood.  
Erastin blocks the system Xc antiporter, preventing the import of cystine and 
export of glutamate at a 1:1 ratio. Cystine is a dimer that can be reduced to cysteine in the 
cell and subsequently is vital to the production of glutathione. Thus, erastin’s mechanism 
of action to induce ferroptosis is to indirectly inhibit GPX4 by depleting glutathione6. On 
the other hand, RSL3 directly inhibits GPX4’s enzyme function leading to an increase in 
lipid ROS and eventual cell death6. These small molecules are efficient ferroptotic 
inducers that can be manipulated to study the pathway in detail within several cellular 
models including but not limited to NSC-34 and mouse embryonic stem cells.  
The NSC-34 cell line is a hybrid cell line developed by fusing the aminopterin-
sensitive neuroblastoma N18TG2 with motor neuron (MN) enriched embryonic day 12-
14 spinal cord cells7. These cells were developed with the anticipation to create a 
neuronal immortal clonally uniform cell line. Its development would be a great feat in 
overcoming some of the setbacks when investigating motor neurons. For instance, this 
cell line is easily cultured and survives several passages. Meanwhile other motor neuron 
differentiation processes require complex media and weeks before any experimentation 
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can commence. Interestingly, these cells also embody several motor neuron properties 
when differentiated, including the following: development of long processes and S-
laminin with leucine-arginine-glutamate (LRE) adhesion motif, the formation of contacts 
with myotubes in culture and increased survival in the presence of neurotrophic factors.7,8 
Overcoming these hurdles and providing a system to investigate motor neurons harboring 
several of its key features led to the use of NSC-34 in the study. 
iNIL cells are a mouse embryonic stem cell line generated by the Mazzoni lab 
also providing an efficient experimental motor neuron model.9 The development of this 
cell line takes advantage of the recent progress in programming cell fate by transcription 
factors, receiving the name iNIL as a result of the three transcription factors Neurogenin 
2, Insulin gene enhancer protein and LIM Homeobox 3.9 Intriguingly, there are two 
proposed models suggested for how programming modules regulate cellular identity: the 
independent model and the synergistic model.9 The former hypothesizes that each 
transcription factor works independently to determine cell fate: binding to distinct genetic 
locations. The latter suggests the transcription factors jointly bind to common regulatory 
elements to work in tandem to promote the specific cell fate.9   
Upon investigation it was determined that Isl1 and Lhx3 directly interact forming 
a heterodimer that synergistically regulate cell fate.9 Contrarily, individual mutations in 
Isl1 and Lhx3 effects the ultimate phenotype indicating the individual model may still be 
involved.9 Although the specific model for how transcription factors program cells could 
not be elucidated, the definitive differentiation of iNIL cells into MNs using these 
transcription factors was well established in the study.9 Researchers developed this 
embryonic stem cell line with NIL factors to be doxycycline inducible allowing for 
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biochemical analysis and validation of successful differentiation.9 Not only were these 
cells effectively differentiated into spinal MNs but the same process could be induced 
using sonic hedgehog and retinoid acid the two patterning signals involved in the normal 
process of MN development.9 Along with NSC-34, iNIL was a useful MN model to 
investigate ferroptosis in this study. 
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CHAPTER 2: MATERIALS AND METHODS 
Cell Culture 
NSC-34 
NSC-34 cells were purchased from Cedarlane (Burlington, NC, USA) (cat. no. 
CLU140). Cells under normal conditions were grown in DMEM 10% FBS with penicillin 
and streptomycin antibiotics (pen/strep). NSC-34 cells were differentiated after 
harvesting using trypsin/EDTA and washing the cell pellet twice with the corresponding 
differentiation medium before seeding into collagen coated culture plates (Corning 
BioCoat, Corning, NY, USA; cat. no. 354400). The following were the four 
differentiation conditions: (a) ‘MEM’ – minimum essential medium a (Thermo Fisher 
Scientific, Waltham, MA, USA; cat. no. 12571063), (b) ‘MEM with atRA’ – MEM with 
1uM all-trans-retinoic acid (Sigma-Aldrich, St Louis, MO, USA; cat. no. R2625), (c) 
‘F12’ – 1:1 of DMEM and Ham’s F12 (Corning Cellgro cat. no. 10-090-CV), and (d) 
‘F12 with atRA’ – F12 medium with 1uM all-trans-retinoic acid. All differentiation 
media were supplemented with 1% FBS, nonessential amino acids (Thermo Fisher 
Scientific, cat. no. 11140050), and pen/strep.  
iNIL 
iNIL cells are thawed and re-suspended in feeder media. Feeder media consists of 
KO DMEM (Gibco cat. no. A1286101), 10% tet-fbs (Corning cat. no. 35075CV), 1% 
glutamine (Gibco cat. no. 25030081), and 1% pen/strep (Gibco cat. no. 15140122). After, 
cells are centrifuged, and the pellet is resuspended in 80/20 media. The cells are then 
plated onto a T-25 flask that had been coated with 0.1% gelatin (Millipore Cat. no. ES-
006-B) for >25min at room temperature and aspirated right before plating. 80 media 
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consists of 50% Advanced DMEM/F12 (Gibco cat. no. 12634028), 50% Neurobasal-A 
(Gibco cat. no. 10888022), 1% B27 serum free (Gibco cat. no. 17504044), 1% N2 (Gibco 
cat. no. 17502048), 1% glutamine (Gibco cat. no. 25030081) and 1% pen/strep (Gibco 
cat. no. 15140122). 20 media consists of KO DMEM (Gibco cat. no. A1286101), 14% 
Tet (-) FBS (Corning cat. no. 35075CV), 1% NEAA (Gibco cat. no. 11140050), 1% 
EmbryoMax Nucleosides (Millipore cat. no. ES-008-D), 1% glutamine (Gibco cat. no. 
25030081) and 1% pen/strep (Gibco cat. no. 15140122). 80/20 media consists of 80% 80 
media, 20% 20 media, 1000 unit/mL of Mouse LIF (Millipore cat. no. ESG1106), 5mM 
CHIR99021 (LClaboratory, Fisher cat. no. NO0664823), 10mM PD0325901 
(LClaboratory, Fisher cat. no. NO0759248) and 0.1mM of beta Mercaptoethanol (Gibco 
cat. no. 21985023). 
iNIL Cells Differentiated into Motor Neurons 
iNIL cells are grown to confluence on a t-25 flask replacing 80/20 media daily. 
When cells are confluent the flask is washed with HBSS without CAMg (HBSS -/-) (cat. 
No. 14175095) and trypsinized with 1mL of TrypLE (Gibco cat.no. 12604021). Cells are 
collected into a 15mL tube with 4mL of feeder media, centrifuged and re-suspended with 
1mL AK media without doxycycline to make a single cell suspension. The suspension is 
diluted with 4mL of AK media without doxycycline and seeded at a cell density of 2.4 
million cells on to a 15cm suspension culture dish. This will be EB day 0, two days later 
the suspension dish is tilted to allow the EBs to sit down towards the bottom of the plate. 
Approximately 25mL of media is aspirated from the top of the dish careful to not disturb 
or lose EBs. 25mL of fresh AK media is added to the dish and the total media is 
measured. Doxycycline is added based on the measured volume, where 1.3uL of 10K x 
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stock of doxycycline is added to every 12mL of media. All cells are resuspended in the 
dish before returning to the incubator. Two days later cells are dissociated and plated in 
motor neuron media, this would represent EB day 4 and MN day 0. To commence 
dissociation all cells in the suspension dish are collected into a 50mL tube. While the 
cells pellet in the tube the empty dish is returned to the incubator. Several minutes later, 
10mL of clear supernatant from the top of the 50mL tube is used to collect leftover EBs 
from the empty dish and added to the 50mL tube. The EBs are pelleted at 700rpm for 
3min, resuspended in 10mL of HBSS -/- and transferred to a 15mL tube. Cells are 
pelleted again at 700 rpm for 3min and resuspended gently with 1mL TrypLE using a 
pipette man. The tube is inverted continuously for 1.5min while cells dissociate. After, 
4mL of feeder media is used to deactivate the trypLE and mechanically dissociate the 
cells. Cells are pelleted at 1000 rpm for 4min and re-suspended with 1mL of AK media to 
make a single cell suspension. 9mL of AK media is used to pipette mix the cells and are 
then filtered into a new 15mL tube. Cells are pelleted once again at 1000 rpm for 4min 
and resuspended in MN media. A cell count at this stage is used to seed cells depending 
on the assay to be completed. Any dish or plate in which the cells will be seeded on must 
be coated with Poly-L-Ornithine and incubated overnight prior to use. 
AK media consists of Advanced DMEM/F12 (Gibco cat. no. 12634028), 
Neurobasal-A (Gibco cat. no. 10888022), 13% knockout-SR (Gibco cat. no. 10828028), 
55uM bME (Gibco cat. no. 21985023), 1x glutamine (Gibco cat. no. 25030081), and 1x 
pen/strep (Gibco cat. no. 15140122).  
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Motor neuron (MN) media consists of Neurobasal-A (Gibco cat. no. 10888022), B27 
serum free (Gibco cat. no. 17504044), bME (Gibco cat. no. 21985023), 1x pen/strep 
(Gibco cat. no. 15140122), 3ug/mL of Doxycycline (Fisher cat. no. AC446060050), 
100uM IBMX (Tocris cat. no. 2845), 25uM qVD (MedChemExpress cat. no. HY-12305), 
10uM Forskolin (Fisher cat. no. BP2520-5), 4uM Fluorodeoxyuridine (Sigma cat. no. 
F0503), 4uM uridine (Sigma cat. no. U3003), 10ng/mL GDNF (PeproTech cat. no. 450-
10), 10ng/mL BDNF (PeproTech cat. no. 450-02), 10ng/mL CNTF (PeproTech cat. no. 
450-13), and 1x glutamine (Gibco cat. no. 25030081). If inducing ferroptosis bME is 
removed from the media and B2 without AO (Gibco cat. no. 10889038) is used in place 
of B27 serum free (Gibco cat. no. 17504044). 
HT-1080/HT-1080 gALOX5 
Cells are cultured in DMEM, 10% FBS, 1% NEAA, 1% Pen/Strep 
HEK-293T 
Cells are cultured in DMEM, 10% FBS, and 1% Pen/Strep. 
All cells were incubated in a tissue culture incubator at 37 °C in a humidified incubator 
containing 5% CO2.  
Chemicals and Antibodies 
Erastin (cat. no. E7781), ferrostatin-1 (Fer-1; cat. no. SML0583), 
propargylglycine (cat. no. P7888), liproxstatin-1 (cat. no. SML1414), and EGTA (cat. no. 
CAS 99590-86-0) were purchased from Sigma- Aldrich. (1S,3R)-RSL3 (cat. no. HY-
100218A) and necrostatin-1 stable (Nec-1s; cat. no. HY-14622) were purchased from 
MedChem Express (Monmouth Junction, NJ, USA), and staurosporine was from LC 
Laboratories (Woburn, MA, USA) (cat. no. S-9300). Rabbit antibody against poly (ADP-
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ribose) polymerase (PARP) was from Cell Signaling Technology (Danvers, MA, USA; 
cat. no. 9532), Rabbit antibody against Choline Acetyltransferase was from Abcam 
(Cambridge, MA,USA; cat. no. ab178850) Rabbit antibody against Class 3 Beta Tubulin 
was from Cell Signaling Technology (Danvers, MA, USA; cat. no. 5568), Mouse 
antibody against Hb9 (Mnx1) was from Developmental Studies Hybridoma Bank (Iowa, 
USA; cat no. 81.5C10), Rabbit antibody against actin was from Santa Cruz 
Biotechnology (Dallas, TX, USA; cat. no. sc-1616-R), Rabbit antibody against Gapdh 
was from Developmental Studies Hybridoma Bank (Iowa, USA; cat no. D16H11), 
secondary antibody against rabbit IgG was from LI-COR Biotechnology (Lincoln, NE, 
USA; cat. no. 925-68071) and secondary antibody against mouse IgG was from LI-COR 
Biotechnology (Lincoln, NE, USA; cat. no. 925-68071) 
Inducing Ferroptosis in NSC-34 Cells 
Assay plates (Corning, cat. no. 3712) were prepared by seeding 2000 NSC-34 
cells per well in 40uL of growth medium into black, clear bottom 384-well plates. The 
assay plate was incubated for 2 days before compound treatment. On the day of the 
experiment, empty 384-well polypropylene plates (Greiner, Monroe, NC, USA; cat. no. 
781281) were filled with 50uL of growth medium except for column 5 where 100uL of 
lethal solution (20uM of erastin and/or RSL3) was transferred. Then, 2-fold serial 
dilution of the lethal solution across columns 5–20 was carried out by transferring 50uL 
of compound solution to the next column successively with mixing. We named this plate 
as ‘1x lethal plate’. Culture media in the assay plate were removed, and NSC-34 cells 
were treated with lethals in a 2- fold dilution series by transferring 40uL of solution from 
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a ‘1x lethal plate’. The assay plate was returned to the culture incubator and maintained 
for 24hr before starting a resazurin viability assay.  
Inducing Ferroptosis in iNIL MNs 
Using the standard differentiation protocol iNIL cells are thawed and grown to 
confluency in a T-25 flask. They are then seeded to a 15cm suspension culture dish 
(Corning, cat. no. 430597). 24hr before dissociation a 96 well plate is coated with 1/10 
dilution of Poly-L-Ornithine (PLO) and incubated overnight. The next day, before 
seeding cells, shake off PLO from plate and wash with 100uL autoclaved water; rinse 
twice with water before use. Cells ready for dissociation are collected and seeded 25,000 
cells per well in 100uL MN media. Two 96 well plates are prepared one labeled as ‘high 
dose’ and the second as ‘low dose’. The first two columns of the ‘high dose’ plate are 
used as the cells only, positive control and is not treated with any drug. The last two 
columns of the ‘low dose’ plate contain media only, serving as the negative control. 
Rows B,C,D will be treated with RSL3 and rows E,F,G will be treated with RSL3 plus 
compound (fer-1, bME, EGTA, Riluzole, Edaravone, Na4PB) the following day. Rows A 
and H are filled with 100uL of water to prevent evaporation. 24hr later a ‘2x lethal plate’ 
is made by filling a 96 well plate with 150uL of MN media excluding rows A, H 
containing water only and column 3 where 300uL of 2x lethal compound (RSL3 and/or 
RSL3 + compound) will be used for the serial dilution. In this case 200 nM of RSL3 is 
the concentration used in column 3. After, 100uL of each well is transferred to the 96 
well plate seeded the day before containing MNs. 24hr after treating cells with 
compound, the standard resazurin viability assay is used to evaluate cell viability. 
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 This assay was used for all iNIL cell viability assays in this study, including 
treatment with the following compounds: bME, fer-1, EGTA, Riluzole, Edaravone, and 
Na4PB. 
Inducing Ferroptosis in HT-1080 
Assay plates (Corning, cat. no. 3712) were prepared by seeding 4,000 HT-1080 
cells per well in 20uL of growth medium into black, clear bottom 384-well plates. The 
same day, compound plates were prepared prior to seeding cells by filling empty 384-
well polypropylene plates (Greiner, Monroe, NC, USA; cat. no. 781281) with 40uL of 
growth medium except for column 5 where 80uL of lethal solution (20uM of erastin 
and/or RSL3) was transferred. Then, 2-fold serial dilution of the lethal solution across 
columns 5–20 was carried out by transferring 40uL of compound solution to the next 
column successively with mixing. We named this plate as ‘2x lethal plate’. HT-1080 cells 
were treated with lethals in a 2- fold dilution series by transferring 20uL solution from a 
‘2x lethal plate’. The assay plate was returned to the culture incubator and maintained for 
24hr before starting a resazurin viability assay. 
Resazurin Viability Assay  
After 1 day of compound treatment, resazurin (Sigma- Aldrich, cat. no. R7017) 
was added to the assay plate to a final concentration of 0.01%. The assay plate was 
incubated further for 1 day to allow reduction of resazurin, which produced red 
fluorescence. The fluorescence intensity was determined using a Victor 2 plate reader 
(Perkin Elmer, Melville, NY, USA) with a 544-nm excitation filter and a 590-nm 
emission filter. Percentage growth inhibition (% GI) was calculated from the following 
formula using fluorescence intensity values:  
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%GI =100 * (1-(X-N)/(P-N) 
where X is cells treated with compound, N is growth medium only, and P is cells without 
any compound.  
Light Microscopy  
Phase contrast images were obtained using a phase contrast inverted microscope 
(Motic, Viking Way Richmon, BC, Canada) equipped with a 910 objective. At least three 
independent fields were acquired for each experimental condition. Representative 
photographs from one field of view are shown.  
Analysis of Lipid Reactive Oxygen Species Generation 
NSC-34 cells were seeded in six-well plates and treated with test compounds for 
the indicated time. On the day of experiment, BODIPYTM581/591 C11 (Thermo Fisher 
Scientific; cat. no. D3861) was added to each well to the final concentration of 1.5uM 
and the culture plate was incubated for 20min at 37 °C. Cells were harvested and washed 
once with Hanks’ balanced salt solution (HBSS; Thermo Fisher Scientific, cat. no. 
14025092) to remove excess BODIPY-C11 dye. After washing, cells were pelleted by 
spinning, and the cell pellet was resuspended in 500uL of HBSS. The cell suspension was 
strained through a 40-uM cell strainer (BD, San Jose, CA, USA), followed by flow 
cytometry analysis using Guava easyCyte Plus (Milli- pore, Billerica, MA, USA). 
BODIPY-C11 signal, which reflects the lipid peroxide level, was measured using the FL1 
channel. Experiments were performed in biological triplicates, and a representative result 
is shown.  
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Gene Expression Analysis by RT-qPCR  
Cells were harvested and washed once with HBSS before freeze storing at 80 °C. 
On the day of experiment, RNA was purified from the cell pellet using the QIAshredder 
and RNAeasy extraction kits (Qiagen, Germantown, MD, USA) according to the 
manufacturer’s instructions. Two milligrams of total RNA per sample was subsequently 
used in a reverse transcription reaction using the TaqMan RT Kit priming with Random 
Hexamers (Thermo Fisher Scientific). The following TaqMan assay primers were 
purchased from Thermo Fisher Scientific: Actb (assay ID Mm02619580_g1), Ngfr (assay 
ID Mm00446296_m1), Chat (assay ID Mm01221880_m1), Gria1 (assay ID 
Mm00433753_m1), Gria2 (assay ID Mm00442822_m1), Gria3 (assay ID 
Mm00497506_m1), Gria4 (assay ID Mm00444754_m1), Grin1 (assay ID 
Mm00433790_m1), Grin2a (assay ID Mm00433802_m1), Grin2b (assay ID 
Mm00433820_m1), Grin2d (assay ID Mm00433822_m1), Mnx1 (a.k.a. Hb9) (assay ID 
Mm01222622_m1), Isl1 (assay ID Mm00517585_m1), Nefm (assay ID 
Mm00456200_m1), Map3k5 (assay ID Mm00434883_m1), Lamb2 (assay ID 
Mm00493080_m1), Itga2 (assay ID Mm00434371_m1), Col16a1 (assay ID 
Mm01180622_m1), Abcc3 (assay ID Mm00551550_m1), Abca1 (assay ID 
Mm00442646_m1), Cth (assay ID Mm00461247_m1), Cbs (assay ID 
Mm00460654_m1), Cyp24a1 (assay ID Mm00487244_m1), Rarb (assay ID 
Mm01319677_m1), and PPIP5K2 (assay ID Hs00274643_m1). Quantitative PCR was 
performed on triplicate samples in 96-well format on a Bio-Rad CFX96 Real-Time PCR 
System (Bio-Rad Laboratories, Hercules, CA, USA). The change in expression of a gene 
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between experimental and control conditions was computed using the ΔΔCt method with 
Actb as an internal reference gene.  
Measuring HB9/GFP Expression in iNIL Cells 
iNIL cells are grown following the standard differentiation protocol. To compare 
differentiated cells with undifferentiated cells, two sets of cells are grown in parallel. One 
is labeled as ‘uninduced’ and the other as ‘induced’. During the doxycycline treatment 
stage of differentiation, ‘induced’ cells follow the standard protocol. Meanwhile, 
‘uninduced’ cells are replaced with fresh media according to the standard protocol but 
without the addition of doxycycline. 2 days later cells were then dissociated, harvested, 
and washed once with Hanks’ balanced salt solution (HBSS; Thermo Fisher Scientific, 
cat. no. 14025092). After washing, cells were pelleted by spinning, and the cell pellet was 
resuspended in 500uL of HBSS. The cell suspension was strained through a 40-uM cell 
strainer (BD, San Jose, CA, USA), followed by flow cytometry analysis using Guava 
easyCyte Plus (Milli- pore, Billerica, MA, USA). 
Immunostaining iNIL Cells 
iNIL cells are incubated overnight in a 96-well plate at 4 degrees Celsius with 
1mL of 100% cold methanol. The next day, the media was aspirated and replaced with 
1mL HBSS +/+ and incubated for 1hr at 4 degree Celsius. After, 500uL of primary 
antibody diluted in odyssey blocking buffer was carefully added to each well. Media is 
added to the surrounding wells to prevent evaporation. The cells are incubated with 
primary antibody at room temperature for 1hr. Then cells are washed with 1mL of HBSS 
+/+ twice before adding 480uL of secondary antibody diluted in odyssey blocking buffer. 
Aluminum foil is used to protect the cells and the antibody from the light. Cells are 
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incubated at room temperature for 30min. Prepare DAPI (Stem Cell Technologies, cat 
no.75004) working solution from stock by diluting 300uM DAPI 1:1000 in HBSS +/+ to 
make 300nm working concentration. Add 500uL of diluted DAPI rocking back and forth 
to mix. The results can be observed under a fluorescent microscope. 
siRNA Transfection  
HT-1080 cells were seeded at a cell density of 175,000 cells per well on a 6-well 
plate. The next day 9uL of Lipofectamine RNA iMAX Reagent was diluted in 150uL of 
Opti-MEM. In a separate eppendorf tube, 30 pmol of siRNA is diluted in 150uL of Opti-
MEM. The diluted siRNA is transferred to the diluted Lipofectamine reagent at a 1:1 
ratio and pipette mixed. The complex was left to form at room temperature for 5min, 
after which, it was added drop wise to one well on a 6-well plate. 48hr later these cells 
along with non-transfected cells were trypsinized and seeded into a black clear bottom 
384-well plate. These assay plates were prepared by seeding 4000 cells in 20uL of 
growth medium per well. These cells were compound treated the same day of seeding. 
Empty 384-well polypropylene plates (Greiner, Monroe, NC, USA; cat. no. 781281) were 
filled with 40uL of growth medium except for column 5 where 80uL of lethal solution 
(20uM of erastin and/or RSL3) was transferred. Then, 2-fold serial dilution of the lethal 
solution across columns 5–20 was carried out by transferring 40uL of compound solution 
to the next column successively with mixing. We named this plate as ‘2x lethal plate’. 
The HT-1080 cells were treated with lethals in a 2-fold dilution series by transferring 
20uL of solution from the ‘2x lethal plate’. The assay plate was returned to the culture 
incubator and maintained for 24hr before starting a resazurin viability assay. 
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CRISPR Molecular Cloning  
To clone the sgRNA guide sequence into the pLCV2 vector backbone, cut 
plasmid and dephosphorylate with FastDigest BsmBI and FastAP at 37 °C for 30min 
with the following: 
      5ug      lentiCRISPRv2  
      3uL      FastDigest BsmBI 
      3uL      Fast AP 
      6uL      10X Fast digest buffer 
      0.6uL   100mM DTT (freshly prepared) 
      XuL     ddH2O 
      60uL    total 
Run the vector on a 0.8% agarose gel for approximately 1hr; excise and gel purify the 
band. Phosphorylate and anneal the Oligonucleotides by combining the following in an 
eppendorf tube: 
1uL        Oligo 1 (100uM) 
1uL        Oligo 2 (100uM) 
1uL        10X T4 Ligation Buffer  
6.5uL     ddH2O 
0.5uL     T4 PNK 
10uL      Total 
Then anneal by heating to 95 °C for 5min in water bath. Turn off the water bath and let 
the tubes gradually cool down and leave to anneal overnight. Dilute annealed 
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oligonucleotides 1:200 the next day. Set up ligation reaction and incubate at room 
temperature for 10min: 
XuL      BsmBI digested plasmid (50ng) 
1uL       Diluted oligo duplex 
5uL       2x Quick ligase buffer 
XuL      ddH2O 
10uL    subtotal 
• Add 1uL Quick ligase for final total of 11uL. 
Transfer 2uL of ligation reaction mixture to STBL3 bacteria for transformation, pick 
colonies, make glycerol stocks and mini prep samples.  
Designing Oligos 
Benchling was the online tool used to design all oligonucleotides for CRISPR 
knockouts. For efficient CRISPR knockout it is suggested to design more than one 
oligonucleotide targeting the same gene but different exons of that gene.  
PolyJet Transfection/Lentivirus Production 
In a 10cm dish HEK 293T cells were seeded at a cell density of 3.35 x106. 24hr 
later the media was replaced in the dish with 9mL of fresh media. In 500uL of DMEM 
with high glucose the following was added and pipette mixed: 10ug of transfer plasmid 
(pLCV2, addgene cat. no. 52961), 7.5ug of packaging plasmid (psPAX2, addgene cat. no. 
12260), and 5ug of envelope plasmid (pMD2.G, addgene cat. no. 12259). In a separate 
tube, 40uL of PolyJet reagent (SignaGen Laboratories cat. no. SL100688) was diluted in 
500uL DMEM with high glucose and pipette mixed. The diluted PolyJet reagent was 
immediately added to the diluted DNA solution all at once, careful not to reverse the 
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mixing order. The solution was vortex mixed immediately and incubated at room 
temperature for 10min (*Never keep the complex forming for more than 20min) The 
complex was added drop wise to the 10cm dish and swirled to mix. 24hr after 
transfection, the media was aspirated and replaced with fresh media. 48hr after 
transfection, 9mL of media was harvested in a 50mL tube and 9mL of fresh media was 
added to the dish. 72hr after transfection, the media was collected again from the dish and 
added to the 50mL tube collected the day before for a total of 18mL. This viral 
supernatant was centrifuged at 3,000 rpm for 10min at room temperature. The pellet was 
discarded, and the viral supernatant was filtered with a 0.45uM low protein binding 
membrane. The viral supernatant was either used immediately or stored at -20 degrees 
Celsius. 
For iNIL cells, after filtering the viral supernatant, the following additional steps 
were taken to ultracentrifuge and concentrate the virus: approximately 8mL of the filtered 
supernatant was aliquoted to 2 ultracentrifuge tubes (ref331372 12.5mL open top). Using 
the balance to make sure the weight is equal, the supernatants were ultracentrifuged at 
16500 rpm for 90min at 4 degrees Celsius in a swinging bucket (SW 41 Ti). The 
supernatant was decanted into a container with 10 percent bleach. The tubes were 
covered in parafilm and stored at 4 degrees Celsius overnight. The next day pellets were 
re-suspended with 500uL of DMEM for a total of 1mL. 
CRISPR Knockout HT-1080 
HT-1080 cells are seeded at a cell density of 150,000 cells per well in 700uL. The 
cells are pipette mixed with 1.3mL of viral supernatant and the 2mL are plated onto a 6-
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well plate and incubated for 2 days. 48hr later cells are trypsinized and seeded again at 
150,000 cells per well in 700uL for a second round of transduction. 
For ACSL4 knockout, three 15mL tubes were prepared with 1.3mL of viral supernatant. 
Two tubes contained viral supernatant targeting ACSL4 exon 3 and one tube with viral 
supernatant targeting ACSL4 exon 5. The viral supernatant was mixed with 150,000 HT-
1080 cells, plated, and incubated for 48hr. On the second round of transduction, three 
15mL tubes were prepared with 1.3mL of viral supernatant again. This times two 15mL 
tubes contained viral supernatant targeting ACSL4 exon 5 and one tube targeting ACSL4 
exon 3. The viral sup was mixed with the HT-1080 cells previously transduced such that 
the following knockouts were generated: HT1080 ACSL4 knockout Exon 3, HT1080 
ACSL4 knockout Exon 5, HT1080 ACSL4 knockout Exon 3 and Exon 5. After another 
48hr, cells were either puromycin or blasticidin selected depending on vector construct. 
CRISPR Knockout iNIL 
A 6-well plate is coated with 2mL of 0.1% gelatin for >25min at room 
temperature and aspirated before use. Confluent iNIL cells are trypsinized from a T-25 
flask and 150,000 cells in 1.7mL of media are mixed with 306uL of concentrated viral 
supernatant and plated on the coated well of the 6-well pate and returned to the incubator. 
2 days later cells are trypsinized and transduced again with 306uL of viral supernatant 
and incubated for another 48hr. 
Blasticidin Selection 
After transducing cells, they are seeded onto a 6-well plate at a cell density of 
75,000 cells per well in media containing 10ug/mL of blasticidin. The controls used for 
blasticidin selection include untransduced cells as well as cells transduced with empty 
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plasmid. 48hr after treatment, cells that were not transduced were completely dead and all 
other cells were growing. These cells are continuously cultured in their corresponding 
growth media supplemented with 10ug/mL of blasticidin.  
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CHAPTER 3: RESULTS 
NSC-34 Cells Are Sensitized to Ferroptosis Upon Differentiation 
NSC-34 is a hybrid cell line: an amalgamation of neuroblastoma and primary 
spinal cord cells. This combination allows for the differentiation of the cells into a motor 
neuron-like state; consequently, enabling the characterization of ferroptosis in two 
distinct cellular conditions. Since ferroptosis sensitivity had not been tested in NSC-34, 
cells were treated with erastin and RSL3 individually.  
Treatment with erastin showed moderate inhibition of growth in NSC-34 cells 
when utilized at a micromolar range of concentration (Fig. 1A). However, there was no 
clear cell death suggesting the cell line was somehow resistant to ferroptosis induction 
via system Xc inhibition. The same drug successfully induced cell death in the control 
cell line HT-1080, confirming both the potency and integrity of the drug used in this 
study (Fig. 1B). RT-qPCR confirmed the expression of xCT in the cell line, negating any 
theories that lack of expression of the gene was the cause of such resistance (Fig. 1D). At 
this point, erastin alone was not sufficient enough to induce ferroptosis. 
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Figure 1: Ferroptosis induction in NSC-34 cell line with erastin and RSL3 
Figure 1 
Erastin or RSL3 alone do not successfully induce ferroptosis in NSC-34 despite both xCT 
and GPX4 expression. (A) NSC-34 cells treated with erastin alone did not induce cell 
death. (B) HT-1080 cells treated with erastin successfully induced ferroptosis confirming 
erastin was viable. (C) NSC-34 cells were sensitized to RSL3 treatment, but this cell 
death could not be rescued by fer-1. (D) RT-qPCR showed that NSC-34 cells did express 
both xCT and GPX4. 
 
Conversely, RSL3 successfully elicited cell death at micro molar range 
concentration in NSC-34 but this cell death could not be suppressed by ferrostatin-1(fer-
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1), a known inhibitor of ferroptosis (Fig. 1C). In the control cell line, HT-1080, cell death 
was induced by RSL3 and rescued by fer-1 (Fig. 2A). RT-qPCR validated expression of 
gpx4 in NSC-34 suggesting that the mechanism of action of RSL3 was not compromised 
(Fig. 1D). The reason for lack of inhibition of fer-1 could be attributed to a deficiency in 
molecular components essential to carrying out the ferroptotic pathway, such as the 
presence of iron. Iron plays a significant role in carrying out ferroptosis as it generates 
lipid peroxides via Fenton chemistry or as a cofactor for lipid oxidizing enzymes. 
Therefore, cells were treated with a combination of erastin and RSL3 in the presence of 
ferric citrate which would provide extracellular iron to facilitate effective carryout of the 
pathway (Fig. 2B). Not only were cells susceptible to the treatment, but they were also 
rescued by fer-1, indicating that ferroptosis was the major pathway at play (Fig. 2C).     
 
Figure 2: Optimal condition to induce ferroptosis in NSC-34 
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Figure 2 
Erastin, RSL3 and 50 μg·mL−1 ferric citrate was the optimal cocktail to induce 
ferroptosis in NSC-34. (A) HT-1080 cells are sensitized to RSL3 and the cell death is 
inhibited by fer-1 showing the integrity of the compounds used in this study. (B) The 
cocktail Erastin, RSL3 and 50 μg·mL−1 ferric citrate was the best method to induce 
ferroptosis in NSC-34 cells and this cell death could be inhibited with fer-1. (C) Cell 
death with FINs is visually represented as well as inhibition of cell death by fer-1. 
 
To further establish that ferroptosis was the major cell death modality involved, 
lipid ROS was measured using a BODIPY assay. This assay showed a significant 
increase of lipid ROS in cells that were treated with the cocktail when compared to the 
DMSO control (Fig. 3A). A Parp assay confirmed that the cell death induced by the 
cocktail was non-apoptotic since the Parp protein was not cleaved after immunoblotting 
(Fig 3B). In comparison, NSC-34 cells treated with staurosporine (STS), an apoptosis 
inducer, did show Parp cleavage (Fig 3B). Moreover, cells treated with caspase inhibitors 
or necroptosis inhibitors such as zVAD-fmk or Necrostatin-1 (Nec-1) respectively, did 
not suppress the cell death (Fig. 3C). However, the ferroptosis inhibitor Liproxstatin-1 
did inhibit cell death induced by ferroptosis similar to fer-1 (Fig. 3C) This data indicates 
that other cell death modalities such as apoptosis and necroptosis are not induced by the 
cocktail. Hence, the optimal condition to test ferroptosis sensitivity in the NSC-34 cell 
line is with a combination of erastin, RSL3 and ferric citrate. 
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Figure 3: Cell death induced by FINs is ferroptosis specific 
Figure 3 
Ferroptosis is the main form of cell death induced by the cocktail Erastin, RSL3 and 50 
μg·mL−1 ferric citrate. (A) Increase in Lipid ROS in cells treated with FINs show that 
ferroptosis is the main cell death modality involved. (B) Lack of PARP cleavage in cells 
treated with FINs suggest cells are dying via a non-apoptotic route. Cells treated with 
staurosporine (STS) were used as the control as there was successful PARP cleavage. (C) 
Cells treated with FINs and either necroptosis or apoptosis inhibitors did not show 
suppression of cell death. However, cells treated with the ferroptosis inhibitor 
Liproxstatin-1 showed suppression of cell death induced by FINs. 
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Now that an effective way to measure ferroptosis sensitivity in the NSC-34 cell 
line was determined, analyzing if there were differences in sensitivity upon 
differentiating the cells into a motor neuron-like state was crucial to understanding the 
pathway in multiple contexts. In order to begin this investigation, establishing the optimal 
differentiation condition was imperative. The literature has suggested several conditions 
in which to differentiate the cell line; leading to the morphological and genetic analysis of 
the cells in several conditions.  
 
Figure 4: Optimal condition to differentiate NSC-34 into a motor neuron-like state 
Figure 4 
MEM 1% FBS without all trans retinoid acid incubated for three days was the optimal 
differentiation condition. (A) All differentiation conditions present the same motor 
neuron-like morphology. (B) Genes with low expression were excluded from determining 
the optimal differentiation condition. (C) RT-qPCR shows the upregulation and 
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downregulation of neuronal markers based on differences in basal media as well as time 
frame of differentiation. 
 
Morphologically, differentiation in NSC-34 manifests itself by forming neurites, 
elongated projections stemming from the cell body. This particular feature was consistent 
for all differentiation conditions (Fig. 4A). Genetically, there were variations in 
differentiation depending on basal media as well as time frame of differentiation. 
Therefore, cells were differentiated under multiple conditions in order to select the 
optimal condition. Normal cells or undifferentiated cells were cultured in DMEM 10% 
Fetal Bovine Serum (FBS). Differentiated cells were cultured under four separate 
conditions: DMEM/F12 1% FBS, DMEM/F12 1% FBS with all-trans retinoid acid, 
MEM 1% FBS, and MEM 1% FBS with all-trans retinoid acid. Cells were differentiated 
under each condition for three days and seven days. At each time point, cells were 
harvested and using RT-qPCR probed for upregulation of neuronal markers. Prior to 
selecting the optimal differentiation condition, genes with low expression levels were 
excluded from the analysis (Fig. 4B). It was deduced that longer differentiation times 
such as seven days led to a downregulation of neuronal markers, whereas a shorter 
differentiation time frame of three days led to an upregulation of neuronal markers: 
Islet1, Chat, Gria4, and Grin1. Furthermore, the basal media consisting of MEM 1% FBS 
without all trans retinoid acid presented as the condition with the most consistent 
upregulation of neuronal markers (Fig. 4C). As a result, cells differentiating for three 
days in MEM 1% FBS without all trans retinoid acid were selected as the optimal 
differentiation condition.  
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Figure 5: NSC-34 differentiated cells are more sensitive to cell death 
Figure 5 
Differentiated cells are sensitized to cell death inducers. (A) Differentiated cells are more 
sensitive to FINs than normal cells. (B) Differentiated cells are also more sensitive to the 
apoptosis inducer staurosporine (STS) than normal cells. 
 
Undifferentiated cells were compared to differentiated cells in terms of ferroptosis 
sensitivity by employing a cell viability assay. All cells were treated with a two-fold 
dilution of a cocktail of ferroptosis inducers (FINs) to generate a dose response curve. 
Normal cells were less sensitive to ferroptosis when compared to its differentiated 
counterpart (Fig. 5A). These results elicited the question whether or not this amplified 
sensitivity in differentiated cells was specific to ferroptosis. For this reason, both normal 
and differentiated cells were treated with the apoptosis inducer staurosporine. Upon 
apoptosis induction, differentiated cells were also more sensitive to cell death than the 
normal cells (Fig. 5B). Therefore, the cell death sensitivity in NSC-34 differentiated cells 
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was not specific to ferroptosis but warranted an investigation as to why these cells were 
more susceptible to cell death than normal cells.  
  
 
Figure 6: Extrinsic factors involved in NSC-34 sensitivity differences 
Figure 6 
Antioxidant properties in FBS influences NSC-34 ferroptosis susceptibility. (A) Basal 
media does not affect sensitivity in differentiated cells but rather the amount of FBS 
influences this sensitization. (B)Neither basal media nor the presence or absence of all 
trans retinoid acid affects sensitization in differentiated cells. 
 
Comparing the two cellular conditions there were definitive external differences that 
were immediately apparent, such as the media conditions. Thus, each component of the 
media was tested as a potential extrinsic factor causing the sensitivity changes. The basal 
media and presence or absence of all trans retinoid acid had no effect on sensitization of 
the cells (Fig. 6B). However, the quantity of fetal bovine serum did affect sensitization 
(Fig 6A). Cells cultured in 10% FBS were more resistant to cell death, whereas cells 
cultured in 1% serum had a significant change in susceptibility to ferroptosis (Fig 6A). 
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These results are attributed to antioxidant properties in the serum protecting the cells 
from death in conditions that were ten-fold higher than the differentiated cells.  
 
Figure 7: Intrinsic factors involved in NSC-34 sensitivity differences 
Figure 7 
David analysis reveals Cth and Cbs downregulation is an intrinsic factor sensitizing 
differentiated NSC-34 cells to ferroptosis. (A) RNA-seq returns the genes upregulated 
and downregulated by two-fold in differentiated NSC-34 cells versus undifferentiated 
cells. (B) David software returns the pathways involved in these gene expression changes 
with emphasis on the catabolic pathways for methionine, isoleucine, threonine and 
valine. (C) The downregulation of the genes Cth and Cbs are confirmed with RT-qPCR. 
(D) PPG is a TS pathway inhibitor as an inhibitor of Cth and consequently inhibiting the 
conversion of cystathionine to cysteine. (E) Normal cells treated with FINs are compared 
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to normal cells treated with both FINs and PPG showing increase sensitization to 
ferroptosis in cells where the TS pathway is inhibited. 
 
Although extrinsic factors seemed to play a major role in sensitivity changes, it is 
possible that certain intrinsic pathways could contribute to the results. Therefore, RNA-
seq revealed gene expression changes in differentiated cells; these gene expression 
changes were confirmed with RT-qPCR (Fig. 7A, Fig. 7C). The genes that were 
upregulated or downregulated two-fold were analyzed using DAVID software. DAVID 
revealed several biological pathways that are manipulated as a result of the fold changes. 
These pathways include nuclear receptors in lipid metabolism, catabolic pathways for 
methionine, isoleucine, threonine, and valine, ECM- receptor interaction, axon guidance, 
and TGF-beta signaling pathway. Out of the five pathways, the catabolic pathways for 
methionine, isoleucine, threonine, and valine were of most interest because of its 
involvement in the Transsulfuration Pathway (TS Pathway) (Fig. 7B). In the TS pathway, 
intracellular methionine is converted into cysteine, an important component of GSH and 
indirect influencer of GPX4 function as previously mentioned (Fig. 7D). Differentiated 
NSC-34 cells have a downregulation of this pathway as a result of the downregulation of 
the genes Cystathionine Gamma-Lyase (CTH) and Cystathionine Beta-Synthase (CBS). 
The downregulation of such genes indirectly affects GPX4 function and also affects GSH 
production leading to an increase in susceptibility to lipid ROS and ferroptosis. Ergo, the 
downregulation of the TS pathway is an intrinsic factor sensitizing the differentiated cells 
to ferroptosis. To solidify this connection, undifferentiated cells were treated with FINs 
and co-treated with PPG or DMSO as the control. PPG is a Cth inhibitor and by 
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comparison a TS pathway inhibitor. Normal cells treated with PPG and FINs experienced 
more sensitivity to ferroptosis when compared to the control (Fig. 7E). This sensitivity 
mirrored the differentiated cells susceptibility to FINs without PPG co-treatment 
verifying the significance of the downregulation of Cth and Cbs in differentiated cells.  
In the NSC-34 cellular model, it was deduced that there were in fact sensitivity 
changes after differentiating the cells due to both extrinsic and intrinsic factors. 
Antioxidant properties in FBS confers resistance to ferroptosis in non-differentiated cells 
and genes in the transsulfuration pathway are downregulated upon differentiation. This 
piqued interest into the role of ferroptosis in other cellular models such as mouse 
embryonic stem cells that could be successfully differentiated into motor neurons.  
Embryonic Stem Cells Differentiated into MNs Are Sensitized to Ferroptosis 
iNIL cells are a doxycycline inducible mouse embryonic stem cell line containing 
a polycistronic expression construct with the three transcription factors: Neurogenin 2 
(Ngn2), Insulin gene enhancer protein (Isl1), and LIM Homeobox 3 (Lhx3).9 These 
transcription factors are activated upon doxycycline induction and are sufficient enough 
to effectively program cells into spinal motor neurons.9  
During this differentiation process, the iNIL cells are grown to confluency and 
seeded to a suspension culture dish in AK media where cells can begin to form embryoid 
bodies (EBs), three dimensional aggregates (Fig. 8A). This stage of differentiation can be 
referred to as EB day 0 (Fig. 8A). Two days later these embryoid bodies are treated with 
doxycycline to promote the differentiation of cells into MNs; this stage being referred to 
as EB day 2 (Fig. 8A). Furthermore, 48hr post doxycycline treatment, cells are 
dissociated and plated in MN media. During this stage, cells are at MN day 0 or EB day 
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4, requiring another two days for a morphological representation of MNs (Fig. 8A). 
Morphologically, one can observe the differences of each stage (Fig. 8B). Interestingly, 
the differentiation of iNIL cells is confirmed both morphologically and through genetic 
analysis. 
 
 
Figure 8: iNIL mouse embryonic stem cells are differentiated into MNs 
Figure 8 
iNIL cells are efficiently differentiated into MNs. (A) iNIL cells are aggregated into EBs 
and differentiated into MNs. (B) The morphological differences between iNIL cells, EBs 
and MNs can be observed. (C) FACs analysis shows an increase in Hb9 as a result of a 
direct increase in gfp expression in early MN cultures. (D) Significant expression of Hb9 
is observed in early MN cultures but decreases as the MNs mature. Asterisk denotes a 
nonspecific band. (E) The mature MN marker Chat shows increased expression in MNs 
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over time. Asterisk denotes a nonspecific band. (F) Mature MN marker Tubb3 shows 
increased expression in MN Day 2 and MN day 5.  Immunostaining with Tubb3 antibody 
reveals a visual manifestation of the Tubb3 gene as the formation of MN axons and 
dendrites 
Genetically, neuronal markers can be probed for expression changes in the 
different stages of development into motor neurons. iNIL cells contain a green 
fluorescence protein (gfp) transgene driven by the Hb9 promoter where an increased 
expression of Hb9 directly correlates with an increased expression of gfp, a fluorescence 
that can be measured using flow cytometry. After the addition of 6.7uM of doxycycline 
there was a 40% increase in gfp expression measured by FACS analysis which directly 
correlated with the increase of Hb9 (Fig. 8C). Hb9 is an early motor neuron marker that 
promotes the differentiation of cells into motor neurons and represses the adjacent 
population of V2 interneurons10. This increase in Hb9 expression is an early event 
imperative in successful differentiation of the stem cells into motor neurons. 
Immunoblotting confirmed no expression of the Hb9 protein in iNIL cells but increased 
expression in dissociated cells which would correspond to MN culture day 0 as well as 
two days after dissociation or MN Day 2 (Fig. 8D). However, five days after dissociation 
there is a decrease in expression of Hb9 which is to be expected because as essential as 
this increase is for differentiation to initiate the change, it is solely an early event (Fig. 
8D). 
Therefore, other neuronal markers must be probed for expression changes to 
ensure successful differentiation. Choline acetyltransferase (ChAT) is an enzyme 
involved in the synthesis of the neurotransmitter acetylcholine and serves as a neuronal 
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marker for mature motor neurons11. Immunoblotting results show that iNIL cells do not 
express the ChAT protein but cells after dissociation have moderate expression (Fig. 8E). 
MN day 2 and MN day 5 show a significant increase in ChAT expression showing the 
progression of the cells into mature motor neurons over time (Fig. 8E). Similar results 
were obtained for Class III Beta-Tubulin (Tubb3), an important protein involved in the 
formation of microtubules, more specifically in the formation and growth of axons and 
dendrites.12,13 An immunoblot revealed that iNIL cells do not express the protein Tubb3, 
while dissociated cells have some expression of the protein; MN day 2 and MN day 5 
have a significant increase in expression of the Tubb3 protein (Fig. 8F). All immunoblots 
used Gapdh as the housekeeping protein, serving as the loading control. Morphologically, 
the development of the embryonic stem cells into motor neurons by forming axons and 
dendrites is prominently influenced by the expression of Tubb3; a manifestation that is 
observed through immunostaining with Tubb3 (Fig. 8F). This data suggests the 
successful differentiation of embryonic stem cells into motor neurons, establishing a 
viable cellular model to investigate ferroptosis sensitivity in MNs. 
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Figure 9: MNs are sensitized to ferroptosis via RSL3 induction 
Figure 9 
MNs are sensitized to ferroptosis induction via RSL3 an event inhibited by fer-1 and 
bME. (A) MNs are not sensitized to ferroptosis via erastin treatment. (B) MNs are 
sensitized to ferroptosis induced with RSL3 treatment. This sensitivity is suppressed with 
the ferroptosis inhibitor bME. (C) Fer-1 also inhibits ferroptosis sensitivity in MNs. (D)  
EBs post dissociation show no difference in sensitivity to RSL3 when compared to MNs at 
Day 2 of culture 
iNIL cells were differentiated into motor neurons and tested for ferroptosis 
sensitivity with erastin and RSL3 individually. Cells subject to erastin treatment at the 
micro molar range of concentration showed no significant cell death or change in 
viability irrespective of the presence or absence of beta-Mercaptoethanol (BME) (Fig. 
9A). This data coincides with the lack of xCT expression in iNIL cells, the target 
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exploited by erastin to induce ferroptosis. However, cells treated with RSL3 on the 
nanomolar range of concentration showed ample sensitivity resulting in cell death and a 
reduction in viability (Fig. 9B). This cell death was rescued when cells were treated with 
both RSL3 and BME (Fig. 9B). BME is a known ferroptosis inhibiter as it promotes 
cellular uptake of cystine, an integral component in GSH and overall antioxidant 
functionality. Differentiated cells susceptible to RSL3 treatment were also treated with 
fer-1, an inhibitor that successfully rescued cellular death (Fig. 9C). This data suggests 
that the cellular death occurring in the differentiated cells is a direct result of the 
ferroptotic pathway.  
Since the NSC-34 motor neuron-like model system showed significant differences 
in normal and differentiated conditions in regard to ferroptosis sensitivity as well as other 
cell death modalities, it was imperative to assess this in iNIL differentiated cells. Cells 
post dissociation with an EB morphology were compared to cells two days post 
dissociation which harbor a MN morphology. In terms of sensitivity to ferroptosis, there 
was no significant difference between the two distinct stages of differentiation, 
suggesting this model is effective in both inducing ferroptosis and studying the pathway 
in MN context (Fig. 9D).  
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Figure 10: IPA analysis reveals pathways involved in MN sensitivity to ferroptosis 
Figure 10 
IPA analysis suggests pathways involved in sensitizing MNs to ferroptosis. (A) RNA-seq 
returns the genes upregulated and downregulated by two-fold in MNs treated with RSL3 
versus MNs treated with the DMSO control. (B) IPA software by QIAGEN returns the 
pathways involved in these gene expression changes. (C) Morphological reduction of 
synapses in cells treated with RSL3  
Now that a viable cellular model exemplifies motor neuron sensitivity to 
ferroptosis, it is essential to find genetic reasons for a lack of resistance to this particular 
form of cell death. This led to an investigation in fold changes of genes in differentiated 
cells with and without RSL3 treatment. Similar to NSC-34, RNA-seq data returned the 
two-fold upregulated and two-fold downregulated genes that were then input into 
Ingenuity Pathway Analysis (IPA) software for analysis of potential pathways involved 
(Fig. 10A). These biological pathways included: Synaptogenesis signaling pathway, 
 
40 
Calcium signaling, Axonal guidance signaling, GABA receptor signaling, and Netrin 
signaling (Fig. 10B).  Why these specific pathways were implicated in the sensitivity of 
MNs to FINs remains to be determined. 
Synaptogenesis signaling pathway refers to the genes involved in the formation of 
synapses between neurons and therefore plays a major role in the nervous system and in 
the efficient functioning of MNs. Upon ferroptosis induction in MNs via RSL3, there is a 
significant reduction in the formation of synapses corresponding to significant cellular 
death which is compatible with the RNA-seq data that shows the genes in this pathway 
are downregulated (Fig. 10C).    
 
Figure 11: Downregulation of calcium signaling pathway drives ferroptosis in MN context 
Figure 11 
Calcium signaling downregulation drives ferroptosis. (A) Electron micrographs of iNIL 
MNs treated with DMSO and EGTA (B)iNIL MNs co-treated with EGTA and fer-1 inhibit 
cell death  
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Calcium signaling pathway is another integral component in MNs as calcium 
(Ca(2+)) participates in the depolarization of the cell. The calcium signaling pathway is 
implicated in MNs sensitized to ferroptosis, returning as one of the several pathways 
downregulated in RNA-seq data, but whether its mechanism of action is to protect cells 
or sensitize cells to ferroptosis is elusive leading to further investigation. Thus, cells were 
treated with ethylene glycol tetra acetic acid (EGTA), a calcium chelator responsible for 
depleting intracellular calcium. Morphologically, MNs treated with EGTA appear 
unhealthy and with no formation of synapses (Fig. 11A). Furthermore, MNs treated with 
EGTA in the presence of ferroptosis inhibitor fer-1 show a suppression of cell death and 
a rescue in cell viability suggesting that the mechanism of action of calcium signaling 
pathway is to drive ferroptosis (Fig. 11B).  
  
Figure 12: IPA Analysis suggests upstream regulator of downregulated genes 
Figure 12 
 
42 
IPA analysis suggests the upstream regulator of downregulated genes. (A) Snca is 
returned by the IPA Software as the upstream regulator of downregulated genes 
After specific pathways were determined to be affected by ferroptosis in MNs 
beginning the groundwork for the pathway’s characterization in neuronal context, it is 
important to understand which specific genes are involved as key regulators. IPA 
Analysis not only puts into context the genes that are being affected but can also return an 
upstream regulator, pinpointing the gene responsible for the cascade of deregulation. In 
this iNIL MN model, Alpha-Synuclein (Snca) was returned as the upstream regulator of 
downregulated genes (Fig. 12). Since there is no way to easily test the role of Snca in MN 
sensitivity to ferroptosis, a genetic tool is required to manipulate the gene and understand 
its function. As a result, the HT-1080 cell line or the parental cell line of ferroptosis was 
employed in order to evaluate the best genetic tool to verify not only Snca but several 
genes that could serve as prospective targets for novel therapies in disease contexts where 
ferroptosis plays a major role, including but not limited to Acyl-CoA Synthetase Long 
Chain Family Member 4 (ACSL4) and Diphosphoinositol Pentakisphosphate Kinase 2 
(PPIP5K2) 
 
PPIP5K2 Knockdown Inhibits Cell Death Induced by Ferroptosis  
The genetic testing to further characterize ferroptosis began with small interfering 
RNA (siRNA), an application useful in implementing knock downs in protein coding 
genes, with PPIP5K2 as the first target. Diphosphoinositol Pentakisphosphate Kinases 
(PPIP5Ks) are genes important in forming the enzymes that catalyze the formation of 
Inositol Pyrophosphates (InsPs), energy rich signaling molecules that regulate a variety of 
cellular processes including vesicle trafficking and apoptosis.14 PPIP5Ks exist in 
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mammals as two isoforms PPIP5K1 and PPIP5K2 and work in conjunction with Inositol 
Hexakisphosphate Kinases (IP6Ks) of which there are three isoforms in mammals IP6K1, 
IP6K2 and IP6K3.14 Together these kinases are essential in forming Inositol 
Pyrophosphates via the following two pathways: PPIP5Ks phosphorylate Insp6 at 
position one to produce 1-Insp7; IP6Ks in turn phosphorylate 1-Insp7 at position five to 
produce Insp8 (Fig. 13A).14 Alternatively, IP6Ks can phosphorylate Insp6 at position five 
to form 5-Insp7 which is then phosphorylated at position one by PPIP5Ks to form Insp8 
(Fig. 13A).14 Thus, PPIP5Ks and IP6Ks are kinases that phosphorylate substrates to 
generate InsPs which are high energy signaling molecules that maintain cellular 
homeostasis by facilitating essential processes. The pathway that the PPIP5K and IP6K 
Kinases manipulate requires further investigation and piqued interest on the potential role 
of PPIP5Ks in the ferroptotic pathway. 
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Figure 13: siRNA knockdown of PPIP5K2 inhibits ferroptosis 
Figure 13 
Silencing PPIP5K2 inhibits ferroptosis. (A) PPIP5Ks route to form the signaling 
molecules InsPs. (B) HT-1080 cells where PPIP5K2 was silenced via Lipofectamine 
transfection are compared to cells still expressing PPIP5K2 in terms of sensitivity 
changes to erastin. HT-1080 cells with siPPIPK2 showed resistance to ferroptosis 
induction. (C) Same as in (B), except the ferroptosis induction in this case was elicited 
with RSL3 treatment. Again, HT-1080 cells with siPPIP5K2 show resistance to 
ferroptosis. (D). RT-qPCR shows downregulation of PPIP5K2 in cells transfected with 
siRNA for the gene. 
 
PPIP5K2 is a gene that encodes a member of the histidine acid phosphatase 
family of proteins.15 Despite containing a histidine acid phosphatase domain, the encoded 
protein functions as an inositol pyrophosphate kinase, and is thought to lack phosphatase 
activity. To investigate how this gene might play a role in ferroptosis it was silenced via 
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siRNA Lipofectamine transfection in the HT1080 cell line. After silencing PPIP5K2, the 
downregulation of the gene was measured and confirmed with RT-qPCR (Fig. 13D). 
Ferroptosis sensitivity levels in the HT-1080 cell line were compared in cells expressing 
PPIP5K2 and in cells where the gene was downregulated. Cells were treated with erastin 
on the micro molar range of concentration and the cell line that still expressed PPIP5K2 
showed ample sensitivity to ferroptosis (Fig. 13B). In contrast, cells where the gene had 
been downregulated showed significantly less sensitivity, rescuing cell death to an extent 
similar to that of an inhibitor of ferroptosis (Fig. 13B). Cells treated with RSL3 on the 
micro molar range of concentration were susceptible to cell death via ferroptosis and the 
cells where the gene was silenced displayed moderate inhibition of cell death (Fig. 13C). 
This data suggests that this gene is important in driving the ferroptotic pathway and its 
absence can suppress this particular cell death modality. However, since siRNA of the 
PPIP5K2 gene did not generate a complete knockout, in order to fully understand the 
importance of this gene and other genes involved in ferroptosis, a modern genetic 
engineering approach known as Clustered Regularly Interspaced Short Palindromic 
Repeats (CRISPR) was tested and optimized in both HT-1080 and iNIL cells. 
CRISPR Knockouts Provide Stable Cell Lines for Genetic Studies in HT-1080 
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and 
CRISPR-associated protein 9 (Cas9) create an efficient genetic engineering approach for 
permanent gene knockouts or knock-ins. This technology harnesses the immune system 
of bacteria, more specifically, the Cas9 enzyme was isolated from Streptococcus 
pyogenes.16 This enzyme is an endonuclease with non-specific targets, thus requiring a 
guide RNA (sgRNA) to guide the enzyme to a specific genetic locus. This attribute 
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allows the manipulation of any gene of interest as long as the integrity and design of the 
sgRNA itself meets the appropriate standards. 
sgRNAs are comprised of two components, a CRISPR RNA (crRNA) and a trans-
activating CRISPR RNA (tracrRNA).16 The crRNA is a 17-20 nucleotide sequence 
complimentary to the target DNA and the tracrRNA serves as a binding scaffold for the 
Cas9 endonuclease.16 The crRNA and tracrRNA exist independently in nature but can be 
synthetically combined to generate single guide RNAs (sgRNA).16 sgRNAs are single 
RNA molecules that contain the custom designed crRNA sequence fused to the scaffold 
tracrRNA sequence, simplifying the genetic engineering approach.16 Although there are 
several CRISPR methods, the CRISPR Cas9 along with sgRNAs were the selected 
approach for introducing CRISPR knockouts and overexpressing cDNA in both HT-1080 
and iNIL cells via lentiviral transduction. Since sgRNAs are responsible for guiding the 
enzyme to a specific genetic locus, its design is imperative to facilitate a successful 
CRISPR knockout. The first parameter to consider when designing a sgRNA is the 
protospacer adjacent motif (PAM) sequence on the non-targeted DNA strand. For the 
CRISPR Cas9 system the PAM sequence is 5’-NGG-3’ where N represents any 
nucleotide.16 This specific sequence drives the cleavage of the DNA by the enzyme as it 
occurs three to four nucleotides upstream of the PAM site. While this 5’-NGG-3’ 
sequence should not be included in the sgRNA, it must be factored in when designing 
target sequences as it limits where the enzyme can bind, and the lack of a PAM sequence 
will disrupt efficient gene editing. To design the 17 to 20 bp oligonucleotides that will 
comprise the sgRNAs, there are several online tools to help filter and maximize on target 
efficiency while minimizing off target effects. Benchling was the online tool used for the 
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design of all sgRNAs in this research.  
 
 
 
Figure 14: CRISPR knockout in HT-1080 cell line 
Figure 14 
CRISPR lentiviral transduction can efficiently generate knockouts in HT-1080 cells. (A) 
HT-1080 transduced with empty pLCV2 were designated as the non-treated cells and 
used as the control. These cells do not show any reduction of gfp visually. (B) Two days 
post transduction with pLCV2-sgGFP, HT-180 cells showed remarkable reduction of gfp 
expression visually. (C) Cells transduced with empty plasmid have similar gfp expression 
to cells that were not treated at all. This suggests pLCV2 empty is a viable control. (D) 
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FACs analysis quantified the reduction of gfp expression showing effective knockout of 
gfp in these cells via CRISPR lentiviral transduction. 
 
After designing oligonucleotides targeting a specific gene of interest, molecular 
cloning methods were used to anneal oligonucleotides and ligate them into the CRISPR 
plasmid, lentiCRISPR v2 (pLCV2). After purification, these plasmids in conjunction with 
envelope plasmid pMD2.G and packaging plasmid psPAX2 were transfected into HEK-
293T cells via PolyJet to induce production of lentivirus. The 48hr and 72hr viral 
supernatant were collected, filtered and either used or stored at -20 degrees Celsius. This 
viral supernatant was used to transduce the target cells to either overexpress or knock out 
a gene of interest. The control testing manipulated the expression of gfp in the HT-1080 
and HT-1080 gALOX5 cell lines. The pLCV2 plasmid containing sgGFP was transfected 
into HEK-293T cells with psPAX2 and pMD2.G; 72hr later the viral supernatant was 
filtered and used to transduce the target cell line HT-1080 gALOX5. HT-1080 gALOX5 
is a human fibrosarcoma cell line that also expresses gfp; this fluorescence can be 
observed visually under a fluorescence microscope and can be measured using a FACS 
machine. These cells were transduced with viral supernatant containing pLCV2 empty 
plasmid as a control as well as a viral supernatant containing the pLCV2-sgGFP.  Two 
days post transduction of the HT-1080 gALOX5 cell line there was a significant decrease 
in gfp expression visually when compared to the control group (Fig. 14A, Fig. 14B). This 
decrease in fluorescence was confirmed with FACS (Fig. 14C, Fig. 14D). The same 
protocol for transfection and transduction was used to overexpress gfp using the PLCV2 
plasmid with gfp CDNA. HT-1080 was the target cell line for the gfp overexpression as it 
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is a cell line of human fibrosarcoma that does not express gfp. For this experiment  
pLCV2 empty plasmid was used as a control; there was a significant increase in the 
expression of gfp visually in cells transduced with 1.3mL of viral supernatant when 
compared to cells transduced with 130uL of viral supernatant (Fig.15A, Fig. 15B). FACS 
analysis confirmed this increase of gfp in the HT-1080 cells (Fig. 15C). These protocols 
were used to create HT-1080 ACSL4 knockout stable cell lines that were blasticidin 
selected.  
 
 
Figure 15: CRISPR is used to overexpress gfp in HT-1080 
Figure 15 
CRISPR lentiviral transduction can efficiently generate gfp overexpression in HT-1080 
cells. (A) HT-1080 cells transduced with 1.3mL of viral sup. shows ample expression of 
gfp visually. (B)HT-1080 cells transduced with 130uL of viral sup. shows slight 
expression of gfp visually. (C) FACs analysis shows pronounced expression of gfp in cells 
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treated with 1.3mL of viral sup. Cells transduced with empty pLCV2 were used as the 
control and designated as the non-treated cells. 
  
ACSL4 Presents as a Potential Genetic Target in Ferroptosis  
These CRISPR protocols were used to create HT-1080 ACSL4 knockout stable 
cell lines that were blasticidin selected. Just as PPIP5K2 was a gene of interest to 
generate knockouts in HT-1080 and iNIL, so was Acyl-CoA Synthetase Long Chain 
Family Member 4 (ACSL4). There are five ACSL enzymes in mammals: among them is 
ACSL4, a gene involved in lipid metabolism and responsible for converting free long-
chain fatty acids into fatty acyl-CoA esters.17 As an isozyme, ACSL4 preferentially 
catalyzes several polyunsaturated fatty acids (PUFAs) such as arachidonic acid.17 It is 
speculated that this gene is important in PUFA metabolism. The oxidation of PUFAs by 
lipoxygenases via a PHKG2-dependent iron pool is necessary for ferroptosis3. For this 
reason, generating an analysis of ACSL4 with CRISPR knockouts will probe for a 
correlation between its PUFA metabolism and PUFA oxidation in ferroptosis in MNs. 
Playing a role in lipid biosynthesis and fatty acid degradation, the presence of this gene 
has been shown in literature to drive ferroptosis. Nonetheless, the function of this gene 
requires further characterization and thus became a target for both iNIL and HT1080 
knockouts via CRISPR lentiviral transduction.  
 HT-1080 cells were transduced with pLHG empty vector as well as pLHG-
sgACSL4 with a specific target for exon 4 (pLHG-sgACSL4 E4). After, stable cell lines 
were generated via blasticidin selection and treated with erastin and RSL3 individually. 
HT-1080 cells not transduced with any virus were designated as no treatment (No Tx) as 
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well as a control for cell viability assays. HT-1080 cells transduced with empty pLHG 
were also used as a control for the experiment. All cells treated with erastin on the 
micromolar range concentration showed no difference in cell viability (Fig. 16A). On the 
other hand, cells treated with RSL3 on the micro molar range concentration showed that 
cells transduced with pLHG-sgACSL4 E4 showed a suppression of cell death (Fig. 16B). 
Non-transduced cells and cells transduced with empty vector displayed similar 
sensitivity, suggesting that the difference in sensitivity is specific to ACSL4 knockout 
(Fig. 16B). It should be noted that the pLHG-sgACSL4 E4 represent a polyclonal 
population and it is a possibility that after single clone selection a monoclonal population 
may give rise to further resistance to ferroptosis.  
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Figure 16: CRISPR knockout of ACSL4 in HT-1080 inhibits ferroptosis 
Figure 16 
HT-1080-sgACSL4 E4 inhibits ferroptosis induced by RSL3 (A) Erastin induces cell 
death in HT-1080 on the micro molar range concentration eliciting no differences in 
sensitivity despite ACSL4 knockout (B) RSL3 induces cell death in HT-1080 on the micro 
molar range concentration and is inhibited by ACSL4 knockout 
 
CRISPR Knockout Optimized for Embryonic Stem Cell Stable Cell Lines  
The CRISPR protocol that was effective in the HT-1080 cell line was not as 
effective in the iNIL embryonic stem cells. There was a slight increase in gfp expression 
in cells transduced with the pLCV2 gfp-CDNA plasmid, but the increase was not as 
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prominent as with the HT-1080 cells (Fig. 17A). As a result, the viral supernatant was 
concentrated using ultracentrifugation in order to deliver more virus to the embryonic 
stem cells. Ultracentrifugation of the virus resulted in better transduction of the iNIL 
cells, significantly increasing the gfp expression (Fig. 17 B). Thus, the genetic 
characterization of Snca, Acsl4 and Ppip5k2 in MN context can commence using this  
CRISPR knockout approach to develop stable cell lines lacking these genes.  
 
Figure 17: CRISPR is used to overexpress gfp in iNIL cells 
 
Figure 17  
iNIL cells are successfully genetically edited when transduced with concentrated virus. 
(A)iNIL cells are slightly transduced to express gfp following the HT-1080 protocol. (B) 
iNIL cells are significantly transduced to express gfp after concentrating virus via 
ultracentrifugation. 
 
iNIL MN Ferroptosis Model Reveals Competency of ALS Drugs  
While these genetic studies will require a lot of work to understand them, the 
benefit of having a working ferroptosis model in iNIL cells can be exploited. iNIL MNs, 
 
54 
where ferroptosis was induced with RSL3, were treated with three distinct ALS drugs: 
Riluzole, Sodium phenyl buturate (Na4PB), and Edaravone. Riluzole is a neuroprotective 
drug that blocks glutamatergic neurotransmission in the CNS.18 It inhibits the release of 
glutamic acid from cultured neurons, from brain slices, and from corticostriatal neurons 
in vivo.18 It is currently a medication used to treat patients with Amyotrophic Lateral 
Sclerosis (ALS). Na4PB is currently in phase 2 trials as a potential ALS treatment. Since 
transcription dysregulation may play a role in the pathogenesis of ALS, Sodium 
phenylbutyrate’s mechanism of action as a histone deacetylase inhibitor is to improve 
transcription and post-transcriptional pathways, promoting cell survival.19 Na4PB has 
shown to be effective in mouse model MNs.19 
Finally, although the exact mechanism of action of edaravone in the treatment of 
ALS is unknown, its therapeutic effect may be due to its known antioxidant properties; 
oxidative stress is a part of the process that kills neurons in patients with ALS.20 Given 
the probable involvement of ferroptosis in neurodegeneration, especially ALS it was 
hypothesized that one of these ALS drugs could potentially suppress cell death by 
ferroptosis. Ferroptosis incited in iNIL MNs by RSL3 was inhibited by only one of the 
three drugs, edaravone (Fig. 18). The antioxidant properties of this particular drug 
coincide with the putative pathway of ferroptosis. 
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Figure 18: ALS drug edaravone inhibits ferroptosis in this MN model 
Figure 18  
Edaravone inhibits ferroptosis in iNIL MNs (A) Riluzole and Na4PB failed to quell cell 
death in iNIL MNs whereas Edaravone successfully restored cell viability. 
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CHAPTER 4: DISCUSSION 
NSC-34 Provides a Basis for Studying Ferroptosis in a MN Context 
While ferroptosis was discovered in the fibrosarcoma cell line HT-1080 and 
demonstrated an effective pathway to elicit in many types of cancer, its intricacies 
suggested it may be involved in other pathologies. This study aimed to highlight the 
connection, if any, that might exist between ferroptosis and motor neurons. Studying 
NSC-34 provided a basis for this aim since these cells were differentiated into a state that 
maximized its motor neuron qualities. 
  The first steps towards this analysis were to establish the optimal differentiation 
condition and the optimal drug treatment conditions. The combination of erastin, RSL3 
and 50 μg·mL−1 ferric citrate induced ferroptosis the most effectively in NSC-34. This 
cell death was attributed solely to ferroptosis since PARP cleavage did not occur, an 
event involved in apoptosis. A signaling cascade specific to apoptosis involves the 
activation of cysteinyl-aspartate proteases (caspases). These caspases initiate cell death 
by cleaving and activating effector caspases.21 PARP-1 is a well-known substrate of 
caspases and its subsequent cleavage has become an apoptosis hallmark.21 Therefore, 
lack of PARP cleavage was significant in proving this cocktail elicits ferroptosis only, a 
non-apoptotic form of cell death. zVAD-fmk functions as a caspase inhibitor as it 
irreversibly binds to the catalytic site of caspase proteases to suppress apoptosis.22 Nec-1 
inhibits the kinase activity of receptor interacting protein kinase 1 (RIPK1), a key 
signaling effector in inducing necroptosis.23 Both inhibitors did not suppress cell death in 
cells treated with FINs, but the well-known ferroptosis inhibitor fer-1 could. This is 
important in demonstrating the sensitization to FINs is specific to ferroptosis only. 
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Furthermore, a BODIPY assay was used to determine changes in lipid ROS levels in the 
sensitized cells. BODIPY is an oxidation sensitive fluorescent lipid peroxidation probe. It 
contains a long carbon chain that causes it to localize in compartments of the cell where 
lipid ROS would manifest. Oxidation of the polyunsaturated butadienyl portion of the 
dye results in a shift of the fluorescence emission peak from ~590 nm to ~510 nm, a 
fluorescence change that can be measured with FACS.24 This increase in the ferroptotic 
hallmark lipid ROS assisted in the solidification of this cocktail as the best way to induce 
ferroptosis in these cells. 
After the optimal differentiation condition of MEM 1% FBS without all trans 
retinoid acid and a three-day incubation period was determined, these cells were subject 
to treatment with FINs to verify and measure sensitivity differences to ferroptosis. It was 
discovered that differentiated cells experienced more cell death and decrease in viability 
when compared to its undifferentiated counterpart. The sensitivity differences between 
differentiated and undifferentiated cells were attributed to serum depletion in the growth 
media of the cells and the downregulation of the genes CTH and CBS after 
differentiation. Interestingly, normal cells subject to FINs and the TS Pathway inhibitor 
PPG were sensitized to ferroptosis similar to the response of differentiated cells. This 
highlighted the importance of the downregulation of Cth and Cbs in regulating 
differentiated cells sensitization to ferroptosis. This data revealed there may in fact be a 
connection between motor neurons and ferroptosis and provided a basis for this study’s 
aim to investigate this connection. However, a cellular model that efficiently 
differentiated into motor neurons provided more insight. 
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Embryonic Stem Cells Provide a Better Model for Studying Ferroptosis Sensitivity 
in MNs 
NSC-34 cells fluctuated in its motor neuron-like qualities depending on basal 
media and time frame of differentiation. Although the optimal differentiation condition in 
this cell line was selected to begin investigating ferroptosis in MN context, embryonic 
stem cells fully differentiated into motor neurons without ambiguity. This was first 
determined morphologically followed by a genetic analysis after probing for certain 
markers. Hb9 upregulation is an early event in MN differentiation; as its expression was 
significant in MN cultures at day 0 and day 2, this was the first indication of successful 
differentiation. This upregulation was quantified through FACS analysis by measuring 
gfp expression changes as a result of the Hb9-gfp reporter system in the embryonic stem 
cells. On the other hand, markers for mature motor neurons such as Chat and Tubb3 were 
upregulated at MN day 2 and MN day 5. Since embryonic stem cells could differentiate 
into motor neurons as determined both morphologically and genetically, this provided an 
efficient cell model to determine if there was a connection between ferroptosis and motor 
neurons. 
Motor Neurons are Sensitized to Ferroptosis 
After differentiation, the motor neurons derived from embryonic stem cells 
showed significant sensitivity to RSL3 treatment, resulting in cell death and a reduction 
in cellular viability.  However, these cells were not susceptible to cell death induced by 
erastin, a result attributed to the lack of expression of xCT in this cell line. The sensitivity 
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induced by RSL3 was rescued after treatment with ferroptosis inhibitor bME. The use of 
bME as a ferroptosis inhibitor became of interest as a result of its use as a component in 
the MN media. Removing bME from the MN media made inducing ferroptosis feasible 
as cellular heath was not compromised and its presence would not interfere with RSL3 
functionality. These findings are important in solidifying both the proper induction of 
ferroptosis and that the cell death is ferroptosis specific. Cell death caused by RSL3 was 
also suppressed by fer-1, another ferroptosis inhibitor, verifying the specificity for 
ferroptosis. For these reasons, it was deduced that motor neurons derived from embryonic 
stem cells, display ample sensitivity to ferroptosis; a significant finding since motor 
neuron deregulation is implicated in neurodegenerative diseases such as ALS and 
Alzheimer’s.  
Moving forward, the questions that arise include why these cells are sensitive to 
ferroptosis and what genes are involved in either driving or inhibiting the pathway. The 
first step in answering this question requires an assessment of which genes are 
upregulated and downregulated, leading to the IPA analysis of gene expression changes. 
Comparing motor neurons treated with FINs and DMSO, the software returned which 
pathways were involved in the genes that were upregulated and downregulated by two-
fold. These biological pathways included: Synaptogenesis signaling pathway, Calcium 
signaling, Axonal guidance signaling, GABA receptor signaling, and Netrin signaling. 
Synaptogenesis is responsible for the formation of synapses; although prominent during 
embryogenesis, it is a process that is also involved in learning and synaptic repair.16 The 
synaptogenesis signaling pathway could potentially serve as a target for novel treatment 
in neurodegenerative disease.25 The fact that this pathway is also affected by ferroptosis 
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in the neuronal context requires further investigation. Calcium signaling mediates several 
processes in the cell with critical importance to neurons due to its involvement in 
synaptic activity and depolarizing signals.26 It is a calcium mediated form of signal 
transduction with roles ranging from excitability and exocytosis to transcription and 
more.26 Axonal guidance signaling involves axon guidance receptors that transmit signals 
to regulate precise pathfinding decisions; it has been studied as a target for axon 
regeneration in cells inflicted with injury or disease.27 Moreover, GABA receptor 
activation inhibits the evoked release of a number of transmitters from brain tissue 
including: glutamate, serotonin, dopamine and GABA itself.28 Deregulation of this 
pathway seems to be involved in neurological disorders. Netrin signaling involves 
netrins: a class of proteins associated with axon guidance; through intracellular signaling 
responses, netrin-1 can trigger either attraction or repulsion of the axon in response to the 
extracellular environment.29 
Of these pathways returned by IPA analysis synaptogenesis signaling, calcium 
signaling, and netrin signaling were determined to be downregulated; while axonal 
guidance signaling and GABA receptor signaling were not determined. In regard to 
synaptogenesis signaling, this downregulation could be observed morphologically in 
immunostained cells treated with RSL3. There is a visible reduction of cells and 
formation of synapses in these cells compared to the DMSO control. With respect to 
calcium signaling, the downregulation of this pathway bought into question whether its 
involvement served as neuroprotection or to drive ferroptosis. With the use of calcium 
chelator EGTA to mimic calcium’s down regulation we could assess this question. It was 
determined that EGTA treatment caused cell death and if co-treated with fer-1, this cell 
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death could be inhibited. These results confirmed that calcium signaling downregulation 
seems to drive ferroptosis. While these findings are noteworthy, there is still much to 
uncover in terms of how these pathways facilitate ferroptosis. 
Several of the pathways that were affected by ferroptosis induction in motor 
neurons seem to also have a role in neurodegeneration. Further testing is required to 
understand in what context ferroptosis causes sensitivity in motor neurons and if there is 
any correlation between this sensitivity and neurodegeneration. 
Why are Motor Neurons Sensitive to Ferroptosis? 
In a 2012 study, adult mice were floxed by flanking exons 2 and 4 of the gpx4 
gene with lox p sites.30  These mice were crossbred with tamoxifen inducible Cre 
transgenic mice, enabling researchers to induce GPX4 ablation after tamoxifen 
treatment.30 The study revealed that GPX4 ablation prompted lethal phenotypes 
including: increased mitochondrial damage, decreased activity of the electron transport 
chain, reduced atp production in the liver, neuronal loss in the hippocampus region and 
increased astrogliosis.30 Lack of GPX4 resulted in eventual death of the mice within two 
weeks.30 The data was indicative of the importance of this gene in both the survival of 
adult animals and neuronal health.  
As we know GPX4 is a major antioxidant compromised in ferroptosis. These 
findings connecting GPX4 to neuronal health, as well as our findings that show direct 
inhibition of GPX4 with RSL3 treatment sensitizes motor neurons, illustrates the 
importance of ferroptosis in neuronal context. This could potentially mean the increased 
sensitivity is significant and warrants further investigation. If the pathway is 
characterized in neurons, its manipulation could lead to future novel therapies. 
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Nonetheless, the next step would involve a detailed study of the genes implicated in this 
sensitization. While RNA-seq revealed certain pathways that may be of interest, the 
stable cell lines with CRISPR knockouts provide the means to manipulate and study 
individual genes in diverse contexts. 
The Importance of Genetic Studies in Understanding Ferroptosis in Future 
Experiments  
Lack of PPIP5K2 expression via siRNA treatment proved to serve as an inhibitor 
of ferroptosis as it rescued cell death when cells were treated with erastin or RSL3. This 
data suggests that the PPIP5K2 gene is important in driving ferroptosis. Creating stable 
cell lines with PPIP5K2 knockouts will help detail this gene’s involvement in driving 
ferroptosis, as well as more information regarding its potential as a therapeutic target 
where ferroptosis is prominent. 
ACSL4 is another gene that appears to drive ferroptosis as it is responsible for the 
formation of PUFAs. PUFA formation in ferroptosis is imperative as it forms lipid 
peroxides in the presence of iron via esterification and oxygenation3. It is one of the 
speculated routes that iron takes advantage of to induce cell death. Therefore, inhibiting 
this gene could rescue cell death and CRISPR knockouts can characterize to what extent 
this gene is involved in ferroptosis. Moreover, Snca revealed as the upstream regulator of 
downregulated genes in the iNIL MN model is yet another target to investigate. 
PPIP5K2, ACSL4 and Snca are not the only genes implicated in the ferroptotic pathway, 
thus the CRISPR knockouts provide a means to detail this pathway and filter which genes 
are of the most importance. These genetic studies are essential because they not only 
 
63 
provide insight on the mechanisms at play when ferroptosis is induced but they also 
provide effective targets. 
iNIL Cells Differentiated into MNs Provide a Viable Model to Screen ALS Drugs 
and Find Potential Therapeutic Targets for Neurodegenerative Pathologies 
The inhibition of ferroptosis by ALS drug edaravone fortifies that this MN model 
is not only effective at delineating ferroptosis in MNs but provides a basis to screen ALS 
drugs. Additionally, this model can be used to identify potential therapies in any 
pathological context depicted by neurodegeneration, especially if compromised 
potentially with ferroptosis involvement. The data here shows the versatility of the iNIL 
MN model and the prospective work that can be achieved with its use. 
Overall, the research in this study supports the main aim to establish a connection 
between ferroptosis and motor neurons providing the groundwork to delve into the 
following: using the iNIL MN model to investigate neurodegeneration, analyzing 
pertinent genetic studies using iNIL for characterization in MNs and HT-1080 for in 
depth characterization of ferroptosis itself. 
To recapitulate, NSC-34 provided the initial model to investigate ferroptosis in 
MNs but as a result of extrinsic factors that caused sensitivity changes, iNIL provided a 
more suitable model. In this process, several genes were highlighted as targets for 
depicting this cell death modality in MNs. In addition to uncovering ferroptosis’ 
mechanism of action, another fundamental feature of the iNIL MN model is its ability to 
investigate the intricacies of neurological pathologies. 
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